THE Department of Health and Aged Care has updated the Immunisation Handbook chapter on Japanese encephalitis (JE).
The department notes that a number of JE cases have been reported in mainland Australia since 2022, and ongoing JE virus transmission is occurring in some states and territories.
JE has a high fatality rate of around 30% in symptomatic cases.
Changes include new and updated recommendations, including use of Japanese encephalitis vaccines in target groups in risk regions of mainland Australia; updates to Japanese encephalitis epidemiology in mainland Australia and the Torres Strait; updates to text on intradermal administration of Imojev vaccine; and updates on vaccine information, including immunogenicity and variations from product information.
See the new chapter HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jun 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jun 25
